A study of supplementation with Curcumin to Diabetics

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2010
INTERVENTION: We determine glucose and insulin with related blood indicators in a hospital. The drug name is Curcumin Qingtang tablet. The dosage given is 2.0 g/60 kg BW/d, equivalent Curcumin 300 mg/kg, take this drug orally for a month. CONDITION: Diabetes mellitus ; Nutritional, Metabolic, Endocrine ; Non‐insulin‐dependent diabetes mellitus PRIMARY OUTCOME: Amended as of 21/09/2010:; 1. Lipids (triglycerides [TG], total cholestrol [TC], low‐density liporotein cholesterol [LDL‐C], high‐density lipoprotein cholesterol [HDL‐C]); 2. Free fatty acids (FFAs); 3. Lipoprotein lipase (LPL); 4. Adipocyte fatty acid‐binding protein (AFABP); 5. Liver ultrasonography; 6. HbA1c; 7. Apolipoproteins (ApoA1/ApoB); 8. Triacylglycerol; 9. Cholesterol; 10. 2‐hour post‐prandial glucose; 11. Homeostasis model assessment ‐ insulin resistance (HOMA‐IR); ; Initial information at time of registration:; 1. Glucose; 2. Insulin SECONDARY OUTCOME: Amended as of 21/09/2010:; 1. Age; 2. Body mass index (BMI); 3. Diabetes duration; 4. Cigarette use; 5. Physical activity level; 6. Food Frequency Questionnaire (FFQ); ; Initial information at time of registration:; 1. Red blood cell; 2. White blood cell; 3. Haemoglobin; 4. Total protein; 5. Albumin; 6. Urea nitrogen; 7. Creatinine; 8. Alanine transaminase; 9. Aspartate transaminase; 10. Platelet count; 11. Height; 12. Weight; 13. Waist circumference; 14. Hip circumference; 15. Blood pressure INCLUSION CRITERIA: 1. Type 2 diabetes mellitus; the condition of patients are stable 2. Fasting blood glucose greater than or equal to 7.8 mmol/L or postprandial blood glucose greater than or equal to 11.1 mmol/L 3. Aged 18 ‐ 65 years, both male and female
Epistemonikos ID: 99fea4622ca7ccc815f3831520a4c280773b21b7
First added on: Aug 22, 2024